drugset / Trial / NCT06743997

A Study to Compare Eutropin Formulations in Healthy Volunteers for Bioavailability, Safety, and Tolerability

NCT06743997

Phase 1 Completed 48 enrolled LG Chem
RandomizedCrossoverOpen-labelOther

Summary

A randomized, Open Label, Single Subcutaneous Dose, 2x2 Crossover Study to Investigate the Relative Bioavailability, Safety and Tolerability among Different Eutropin Formulations in Healthy Volunteers

Timeline

Start
2025-01-13
Primary completion
2025-04-15
Completion
2025-04-15

Drugs

EvaluationDrugModalityDoseRoute
Subject Somatropin Protein / enzyme biologic Subcutaneous

Indications

No indication recorded.